Home Top Movers Oncternal Therapeutics, Inc. (ONCT) Stock Price Soared By A Staggering 13.13%. Here’s...

Oncternal Therapeutics, Inc. (ONCT) Stock Price Soared By A Staggering 13.13%. Here’s What Happened.

Oncternal Therapeutics, Inc. (ONCT), a clinical-stage biopharmaceutical company specializing in manufacturing unique oncology therapies, announced the latest interim clinical data from the ongoing Phase 1/2 CIRLL (Cirmtuzumab and Ibrutinib targeting ROR1 for Leukemia and Lymphoma) clinical trial, to be presented at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

At last check in after-market trading, shares of Oncternal Therapeutics Inc. (ONCT) were up 13.13% at $6.29. ONCT’s stock closed the last session at $5.56, decreasing -4.14% or -$0.24. Shares of the company fluctuated between $5.37 and $5.67 throughout the day. The shares of Oncternal Therapeutics Inc. have advanced 9.45% in the last five days; however, they have lost -3.30% over the last month.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

Updated Interim Data

In the CIRLL study, cirmtuzumab, a potential anti-ROR1 monoclonal antibody, is being assessed to be used with ibrutinib in patients affected with MCL and CLL. The clinical trial is being supervised in association with the UC San Diego School of Medicine and is partly funded by the California Institute for Regenerative Medicine.

Patients consisted of heavy risk factors and were stiffly pre-treated at study entry, 70% with a high Ki-67 proliferative index, 15% with intermediate to high prognostic score, and an average of two methodical previous therapies.

The ORR of 83% (with 15 out of a total 18 patients assessed), which was inclusive freshly registered patients with comparatively short follow-up time, and can be compared to the 87% ORR (13 of 15 evaluable patients) who were priorly presented at the American Society of Hematology (ASH) 2020 Annual Meeting.

Eight of 18 (44%) assessed patients partly got a response (PR) and two patients (11%) consisted of stable disease (SD), for a total clinical best benefit rate of 94%. The finished response rate was 39% (7 of 18 assessed patients)

The combination of cirmtuzumab and ibrutinib had had a high tolerance, with treatment usage producing harmful events and blood aberrations consistent with, or moderately lower than those reported for the only ibrutinib. No dose-limiting toxicities have been established and no serious negative scenarios are linked to cirmtuzumab alone.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Conclusion

Positive Interim data combined with a low rate of toxicity as compared to the only ibrutinib has surged investor interest for Oncternal Therapeutics, with ONCT stock price rising immensely at last check.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

CureVac Inc. (CVAC) stock soar during pre-market trading. Here’s what you should know?

CureVac Inc. (NASDAQ: CVAC) stock declined by 38.99% at the last close while the CVAC stock price gains by 11.34% in the pre-market trading...

Why Iconix Brand Group Inc (ICON) stock turnaround in the after-hours on Thursday?

Iconix Brand Group Inc (ICON) shares started the Thursday, June 17, 2021, trading be losing 1.87% and close the normal trading session at $3.14...

ISun Inc. (ISUN) stock surged during current market trading. Here’s the update

ISun Inc. (NASDAQ: ISUN) stock gained by 19.51% in the current market trading. iSun, based in Burlington, Vermont, is a company built on ideals...

The Trade Desk Inc. (TTD) stock plunged during pre-market. Here’s to know why?

The Trade Desk Inc. (NASDAQ: TTD) stock gained by 0.76% at last close whereas the TTD stock price declines by 90.03% in the pre-market...

Synaptogenix Inc. (SNPX) stock soars during after-hour trading. Why so?

Synaptogenix Inc. (NASDAQ: SNPX) stock gained by 6.33% at last close while the SNPX stock price rises further by 13.48% in the after-hours trading...

CureVac Inc. (CVAC) stock soar during pre-market trading. Here’s what you should know?

CureVac Inc. (NASDAQ: CVAC) stock declined by 38.99% at the last close while the CVAC stock price gains by 11.34% in the pre-market trading...

Anpac Bio-Medical Science Inc. (ANPC) stock soars during pre-market trading. Here’s the update

Anpac Bio-Medical Science Inc. (NASDAQ: ANPC) stock gained by 0.46% at last close while the ANPC stock price surged by 22.40% in the pre-market...

VivoPower International Inc. (VVPR) stock soars during pre-market trading. What’s driving it high?

VivoPower International Inc. (NASDAQ: VVPR) stock gained by 1.13% at last close while the VVPR stock price surged during pre-market trading by 1.54%. VivoPower...

Related News

Edesa Biotech Inc. (EDSA) stock surged during current market trading. Here’s to know why?

Edesa Biotech Inc. (NASDAQ: EDSA) stock gained by 4.22% in the current market trading. Edesa Biotech is a clinical-stage biopharmaceutical business dedicated on the...

VivoPower International Inc. (VVPR) stock soars during pre-market trading. What’s driving it high?

VivoPower International Inc. (NASDAQ: VVPR) stock gained by 1.13% at last close while the VVPR stock price surged during pre-market trading by 1.54%. VivoPower...

Cleveland BioLabs Inc. (CBLI) stock surged during after-hour session. Here’s what’s happening?

Cleveland BioLabs Inc. (NASDAQ: CBLI) stock declined by 3.58% at the last close while the CBLI stock price gains by 17.53% during the after-hour...

Why Ares Commercial Real Estate Corp (ACRE) stock plummeted on Thursday?

Ares Commercial Real Estate Corporation (ACRE) shares slipped 4.35% in after-hours on Thursday, June 17, 2021, and close the trading at $15.60. Earlier, ACRE's...

Nano-X Imaging Ltd. (NNOX) stock gained in the current market trading. Here’s to know why?

Nano-X Imaging Ltd. (NASDAQ: NNOX) stock gained by 14.90% in the current market trading. Nanox which is an Israeli company started by serial entrepreneur...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam